Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Mar;95(3):1345–1352. doi: 10.1172/JCI117785

180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.

M F Jonkman 1, M C de Jong 1, K Heeres 1, H H Pas 1, J B van der Meer 1, K Owaribe 1, A M Martinez de Velasco 1, C M Niessen 1, A Sonnenberg 1
PMCID: PMC441474  PMID: 7883981

Abstract

Generalized atrophic benign epidermolysis bullosa (GABEB) is a form of nonlethal junctional epidermolysis bullosa characterized by universal alopecia and atrophy of the skin. We report a deficiency of the 180-kD bullous pemphigoid antigen in three patients with GABEB from unrelated families. We screened specimens of clinically normal skin from nine junctional epidermolysis bullosa patients (3 GABEB, 4 lethal, 1 cicatricial, 1 pretibial) by immunofluorescence using monoclonal antibodies to the 180-kD and 230-kD bullous pemphigoid antigens (BP180 and BP230). In the skin of the three GABEB patients there was no reactivity with antibodies to BP180, whereas staining for BP230 was normal. In the skin of the other six, non-GABEB patients, included in this study the expression of BP180 and BP230 was normal. Immunoblot analysis of cultured keratinocytes from one of the GABEB patients also failed to detect BP180 antigen, whereas BP230 was present in normal amounts. The deficient expression of BP180 is reflected in the RNA message, as in Northern blot analysis a reduced amount of BP180 transcripts, although of normal length, were detected. Interestingly, in another GABEB patient there were not-involved areas of skin, in which blistering could not be induced by rubbing. Biopsy material from these areas showed interrupted staining for BP180. There was no staining for BP180 in areas of clinically normal but involved skin of this patient. In conclusion, this study reveals that the BP180 antigen is deficient and the BP180 mRNA is reduced in generalized atrophic benign epidermolysis bullosa.

Full text

PDF
1345

Images in this article

1347Image
on p.1347
1348Image
on p.1348
1349Image
on p.1349
1349Image
on p.1349
1350Image
on p.1350
1350Image
on p.1350
1350Image
on p.1350

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aberdam D., Galliano M. F., Vailly J., Pulkkinen L., Bonifas J., Christiano A. M., Tryggvason K., Uitto J., Epstein E. H., Jr, Ortonne J. P. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet. 1994 Mar;6(3):299–304. doi: 10.1038/ng0394-299. [DOI] [PubMed] [Google Scholar]
  2. Amagai M., Elgart G. W., Klaus-Kovtun V., Stanley J. R. Southern analysis of the 230-kD bullous pemphigoid antigen gene in normal humans, animals, and patients with junctional epidermolysis bullosa. J Invest Dermatol. 1991 Aug;97(2):249–253. doi: 10.1111/1523-1747.ep12480358. [DOI] [PubMed] [Google Scholar]
  3. Bruckner-Tuderman L., Rüegger S., Odermatt B., Mitsuhashi Y., Schnyder U. W. Lack of type VII collagen in unaffected skin of patients with severe recessive dystrophic epidermolysis bullosa. Dermatologica. 1988;176(2):57–64. doi: 10.1159/000248673. [DOI] [PubMed] [Google Scholar]
  4. Bruins S., de Jong M. C., Heeres K., Wilkinson M. H., Jonkman M. F., van der Meer J. B. Fluorescence overlay antigen mapping of the epidermal basement membrane zone: I. Geometric errors. J Histochem Cytochem. 1994 Apr;42(4):555–560. doi: 10.1177/42.4.8126380. [DOI] [PubMed] [Google Scholar]
  5. Fine J. D., Bauer E. A., Briggaman R. A., Carter D. M., Eady R. A., Esterly N. B., Holbrook K. A., Hurwitz S., Johnson L., Lin A. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol. 1991 Jan;24(1):119–135. doi: 10.1016/0190-9622(91)70021-s. [DOI] [PubMed] [Google Scholar]
  6. Fine J. D. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin. J Invest Dermatol. 1985 Jul;85(1):47–49. doi: 10.1111/1523-1747.ep12275025. [DOI] [PubMed] [Google Scholar]
  7. Giudice G. J., Emery D. J., Diaz L. A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol. 1992 Sep;99(3):243–250. doi: 10.1111/1523-1747.ep12616580. [DOI] [PubMed] [Google Scholar]
  8. Giudice G. J., Emery D. J., Zelickson B. D., Anhalt G. J., Liu Z., Diaz L. A. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol. 1993 Nov 15;151(10):5742–5750. [PubMed] [Google Scholar]
  9. Hashimoto I., Schnyder U. W., Anton-Lamprecht I. Epidermolysis bullosa hereditaria with junctional blistering in an adult. Dermatologica. 1976;152(2):72–86. doi: 10.1159/000251166. [DOI] [PubMed] [Google Scholar]
  10. Hashimoto T., Amagai M., Ebihara T., Gamou S., Shimizu N., Tsubata T., Hasegawa A., Miki K., Nishikawa T. Further analyses of epitopes for human monoclonal anti-basement membrane zone antibodies produced by stable human hybridoma cell lines constructed with Epstein-Barr virus transformants. J Invest Dermatol. 1993 Mar;100(3):310–315. doi: 10.1111/1523-1747.ep12469916. [DOI] [PubMed] [Google Scholar]
  11. Hessle H., Sakai L. Y., Hollister D. W., Burgeson R. E., Engvall E. Basement membrane diversity detected by monoclonal antibodies. Differentiation. 1984;26(1):49–54. doi: 10.1111/j.1432-0436.1984.tb01372.x. [DOI] [PubMed] [Google Scholar]
  12. Hieda Y., Nishizawa Y., Uematsu J., Owaribe K. Identification of a new hemidesmosomal protein, HD1: a major, high molecular mass component of isolated hemidesmosomes. J Cell Biol. 1992 Mar;116(6):1497–1506. doi: 10.1083/jcb.116.6.1497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hintner H., Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol. 1982 Jun;118(6):375–384. [PubMed] [Google Scholar]
  14. Hogervorst F., Kuikman I., Noteboom E., Sonnenberg A. The role of phosphorylation in activation of the alpha 6A beta 1 laminin receptor. J Biol Chem. 1993 Sep 5;268(25):18427–18430. [PubMed] [Google Scholar]
  15. Ishiko A., Shimizu H., Kikuchi A., Ebihara T., Hashimoto T., Nishikawa T. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest. 1993 Apr;91(4):1608–1615. doi: 10.1172/JCI116368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jones J. C., Kurpakus M. A., Cooper H. M., Quaranta V. A function for the integrin alpha 6 beta 4 in the hemidesmosome. Cell Regul. 1991 Jun;2(6):427–438. doi: 10.1091/mbc.2.6.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jonkman M. F., de Jong M. C., Heeres K., Sonnenberg A. Expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa. J Invest Dermatol. 1992 Oct;99(4):489–496. doi: 10.1111/1523-1747.ep12616168. [DOI] [PubMed] [Google Scholar]
  18. Jonkman M. F., de Jong M. C., van der Meer J. B. Cicatricial junctional epidermolysis bullosa. J Am Acad Dermatol. 1994 Aug;31(2 Pt 1):286–288. doi: 10.1016/s0190-9622(08)81983-4. [DOI] [PubMed] [Google Scholar]
  19. Kennel S. J., Foote L. J., Falcioni R., Sonnenberg A., Stringer C. D., Crouse C., Hemler M. E. Analysis of the tumor-associated antigen TSP-180. Identity with alpha 6-beta 4 in the integrin superfamily. J Biol Chem. 1989 Sep 15;264(26):15515–15521. [PubMed] [Google Scholar]
  20. Labib R. S., Anhalt G. J., Patel H. P., Mutasim D. F., Diaz L. A. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986 Feb 15;136(4):1231–1235. [PubMed] [Google Scholar]
  21. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  22. Leigh I. M., Eady R. A., Heagerty A. H., Purkis P. E., Whitehead P. A., Burgeson R. E. Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 1988 May;90(5):639–642. doi: 10.1111/1523-1747.ep12560795. [DOI] [PubMed] [Google Scholar]
  23. Li K. H., Sawamura D., Giudice G. J., Diaz L. A., Mattei M. G., Chu M. L., Uitto J. Genomic organization of collagenous domains and chromosomal assignment of human 180-kDa bullous pemphigoid antigen-2, a novel collagen of stratified squamous epithelium. J Biol Chem. 1991 Dec 15;266(35):24064–24069. [PubMed] [Google Scholar]
  24. Li K., Tamai K., Tan E. M., Uitto J. Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5'-end of the gene and the 3'-untranslated region of the mRNA. J Biol Chem. 1993 Apr 25;268(12):8825–8834. [PubMed] [Google Scholar]
  25. Nishizawa Y., Uematsu J., Owaribe K. HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J Biochem. 1993 Apr;113(4):493–501. doi: 10.1093/oxfordjournals.jbchem.a124072. [DOI] [PubMed] [Google Scholar]
  26. Owaribe K., Nishizawa Y., Franke W. W. Isolation and characterization of hemidesmosomes from bovine corneal epithelial cells. Exp Cell Res. 1991 Feb;192(2):622–630. doi: 10.1016/0014-4827(91)90084-8. [DOI] [PubMed] [Google Scholar]
  27. Paller A. S., Fine J. D., Kaplan S., Pearson R. W. The generalized atrophic benign form of junctional epidermolysis bullosa. Experience with four patients in the United States. Arch Dermatol. 1986 Jun;122(6):704–710. [PubMed] [Google Scholar]
  28. Pulkkinen L., Christiano A. M., Airenne T., Haakana H., Tryggvason K., Uitto J. Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet. 1994 Mar;6(3):293–297. doi: 10.1038/ng0394-293. [DOI] [PubMed] [Google Scholar]
  29. Sonnenberg A., Janssen H., Hogervorst F., Calafat J., Hilgers J. A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem. 1987 Jul 25;262(21):10376–10383. [PubMed] [Google Scholar]
  30. Tidman M. J., Eady R. A. Hemidesmosome heterogeneity in junctional epidermolysis bullosa revealed by morphometric analysis. J Invest Dermatol. 1986 Jan;86(1):51–56. doi: 10.1111/1523-1747.ep12283807. [DOI] [PubMed] [Google Scholar]
  31. Tomson A. M., Scholma J., Blaauw E. H., Rosingh H. J., Dikkers F. G. Improved in vitro generation of epithelial grafts with oral mucosa. Transplantation. 1994 Dec 15;58(11):1282–1284. [PubMed] [Google Scholar]
  32. Verrando P., Hsi B. L., Yeh C. J., Pisani A., Serieys N., Ortonne J. P. Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res. 1987 May;170(1):116–128. doi: 10.1016/0014-4827(87)90121-2. [DOI] [PubMed] [Google Scholar]
  33. Verrando P., Schofield O., Ishida-Yamamoto A., Aberdam D., Partouche O., Eady R. A., Ortonne J. P. Nicein (BM-600) in junctional epidermolysis bullosa: polyclonal antibodies provide new clues for pathogenic role. J Invest Dermatol. 1993 Nov;101(5):738–743. doi: 10.1111/1523-1747.ep12371685. [DOI] [PubMed] [Google Scholar]
  34. Yamada Y., Dekio S., Jidoi J., Ishimoto T., Yoshioka T. Epidermolysis bullosa atrophicans generalisata mitis--report of a case with renal dysfunction. J Dermatol. 1990 Nov;17(11):690–695. doi: 10.1111/j.1346-8138.1990.tb03012.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES